The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Percutaneous radiofrequency ablation of hepatocellular lesions in segment II of the liver: a risk factor for cardiac tamponade
Silverman ER, Lai YH, Osborn IP, Yudkowitz FS. J Clin Anesth. 2013 Aug 26. pii: S0952-8180(13)00221-3. doi: 10.1016/j.jclinane.2013.04.014. [Epub ahead of print]
Source
Department of Anesthesiology, The Mount Sinai Medical Center, New York, NY 10029, USA. Electronic address: eric.silverman@mountsinai.org.
Abstract
Percutaneous radiofrequency ablation (PRFA) is a minimally invasive procedure used for the treatment of small hepatocellular carcinomas. Percutaneous radiofrequency ablation is regarded as a much safer alternative to surgical resection or orthotopic liver transplantation. However, serious complications, including cardiac tamponade, have been reported. Two cases of severe cardiac tamponade during PRFA were successfully treated.